お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:世界におけるネブライザー市場の規模、シェア、動向分析、予測
市場調査レポート
商品コード
615517

世界におけるネブライザー市場の規模、シェア、動向分析、予測

Nebulizer Market Size, Share & Trends Analysis Report By Type (Jet, Mesh, Ultrasonic), By End Use (Hospitals and Clinics, Emergency Centers), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2020 - 2027

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 100 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=112.06円
世界におけるネブライザー市場の規模、シェア、動向分析、予測
出版日: 2020年02月26日
発行: Grand View Research, Inc.
ページ情報: 英文 100 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは世界のネブライザー市場について調査しており、市場の規模、動向や予測、タイプ・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 調査方法と範囲

  • 市場セグメントと範囲
  • 情報調達
  • 情報分析
  • 市場形成とデータの可視化
  • データ検証と公開

第2章 エグゼクティブサマリー

  • 市場の展望
  • セグメント別の展望
  • 競合の洞察

第3章 ネブライザーの市場変数、動向、および展望

  • 市場リネージュの展望
  • 浸透および成長の見通しのマッピング
  • 段階別製品パイプライン分析
  • ユーザーの視点分析
  • 地域別、国別、種類別の主要エンドユーザーのリスト
  • 規制の枠組み
  • 市場力学
  • ネブライザー:市場分析ツール

第4章 ネブライザー市場分析:セグメント別

  • 定義と範囲
  • 製品市場シェア分析
  • セグメント別ダッシュボード
  • 世界のネブライザー市場 タイプ別
  • 市場規模、予測および動向分析

第5章 ネブライザー市場分析:地域別

  • 定義と範囲
  • 地域市場シェア分析
  • 地域市場ダッシュボード
  • 地域市場のスナップショット(市場規模、CAGR、主要な産業、主な企業、主な動向)
  • 地域市場シェアおよび主要企業
  • 要因別SWOT分析(政治的・法的・経済的・技術的)
  • 市場規模、予測、取引量および動向分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東およびアフリカ

第6章 ネブライザー市場 - 競合分析

  • 主要市場参入企業別の最近の動向と影響分析
  • 企業/競争の分類(主なイノベーター、マーケットリーダー、新興企業)
  • 仕入先の展望
  • 主な販売代理店とチャネルパートナーのリスト
  • 主要顧客
  • 主要企業の市場シェア分析
  • 公開会社
  • 民間企業
  • サプライヤーランキング
  • 主要企業のプロファイル
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 List of nebulizer service providers
  • Table 4 North America nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 5 North America mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 6 North America nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 7 U.S. nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 8 U.S. mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 9 U.S. nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 10 Canada nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 11 Canada mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 12 Canada nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 13 Europe nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 14 Europe mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 15 Europe nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 16 U.K. nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 17 U.K. mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 18 U.K. nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 19 Germany nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 20 Germany mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 21 Germany nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 22 France nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 23 France mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 24 France nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 25 Italy nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 26 Italy mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 27 Italy nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 28 Spain nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 29 Spain mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 30 Spain nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 31 Russia nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 32 Russia mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 33 Russia nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 34 Asia Pacific nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 35 Asia Pacific mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 36 Asia Pacific nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 37 Japan nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 38 Japan mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 39 Japan nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 40 China nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 41 China mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 42 China nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 43 India nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 44 India mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 45 India nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 46 Malaysia nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 47 Malaysia mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 48 Malaysia nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 49 Singapore nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 50 Singapore mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 51 Singapore nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 52 Philippines nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 53 Philippines mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 54 Philippines nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 55 Indonesia nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 56 Indonesia mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 57 Indonesia nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 58 Latin America nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 59 Latin America mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 60 Latin America nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 61 Brazil nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 62 Brazil mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 63 Brazil nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 64 Mexico nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 65 Mexico mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 66 Mexico nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 67 MEA nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 68 MEA mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 69 MEA nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Table 70 South Africa nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 71 South Africa mesh nebulizer market, by type, 2016 - 2027 (USD Million)
  • Table 72 South Africa nebulizer market, by end use, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Nebulizer market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Information procurement
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity Flow Analysis
  • Fig. 10 Nebulizer executive summary, 2019 (USD Millions)
  • Fig. 11 Nebulizer market revenues, 2019 (USD Millions)
  • Fig. 12 Segment outlook
  • Fig. 13 Strategy framework
  • Fig. 14 Parent market outlook
  • Fig. 15 Ancillary market outlook
  • Fig. 16 Market trends and outlook
  • Fig. 17 Penetration & growth prospect mapping
  • Fig. 18 Nebulizer market trend analysis
  • Fig. 19 Nebulizer market timeline analysis
  • Fig. 20 Market trends & outlook
  • Fig. 21 Market driver relevance analysis (Current & future impact)
  • Fig. 22 Treatment cost by healthcare setting (Average cost per day in USD)
  • Fig. 23 Global geriatric population, 2012 - 2020 (Million)
  • Fig. 24 Market restraint relevance analysis (Current & future impact)
  • Fig. 25 Porter's five forces analysis
  • Fig. 26 PESTLE analysis
  • Fig. 27 Market participant categorization
  • Fig. 28 Nebulizer company market position analysis
  • Fig. 29 Respiratory diseases prevalence
  • Fig. 30 Type of nebulizers in respiratory diseases clinical trials
  • Fig. 31 Clinical trials by products
  • Fig. 32 Clinical trials by companies
  • Fig. 33 Nebulizer market type outlook: Key takeaways
  • Fig. 34 Nebulizer market: type movement analysis
  • Fig. 35 Jet nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 36 Mesh nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 37 Ultrasonic nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 38 Nebulizer market end use outlook: Key takeaways
  • Fig. 39 Nebulizer market: end use movement analysis
  • Fig. 40 Hospitals and clinics market, 2016 - 2027 (USD Million)
  • Fig. 41 Emergency Centers market, 2016 - 2027 (USD Million)
  • Fig. 42 Home healthcare market, 2016 - 2027 (USD Million)
  • Fig. 43 Nebulizer market: regional movement analysis
  • Fig. 44 Regional market dashboard
  • Fig. 45 Nebulizer market regional outlook: Key takeaways
  • Fig. 46 Regional market place: Key takeaways
  • Fig. 47 North America nebulizer market, by country, 2016 - 2027 (USD Million)
  • Fig. 48 North America nebulizer market, by type, 2016 - 2027 (USD Million)
  • Fig. 49 North America nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Fig. 50 U.S. nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 51 Canada nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 52 Europe nebulizer market, by country, 2016 - 2027 (USD Million)
  • Fig. 53 Europe nebulizer market, by type, 2016 - 2027 (USD Million)
  • Fig. 54 Europe nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Fig. 55 U.K. nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 56 Germany nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 57 France nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 58 Italy nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 59 Spain nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 60 Russia nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 61 Asia Pacific nebulizer market, by country, 2016 - 2027 (USD Million)
  • Fig. 62 Asia Pacific nebulizer market, by type, 2016 - 2027 (USD Million)
  • Fig. 63 Asia Pacific nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Fig. 64 Japan nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 65 China nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 66 India nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 67 Malaysia nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 68 Singapore nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 69 Philippines nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 70 Indonesia nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 71 Latin America nebulizer market, by country, 2016 - 2027 (USD Million)
  • Fig. 72 Latin America nebulizer market, by type, 2016 - 2027 (USD Million)
  • Fig. 73 Latin America nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Fig. 74 Brazil nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 75 Mexico nebulizer market, 2016 - 2027 (USD Million)
  • Fig. 76 MEA Nebulizer market, by country, 2016 - 2027 (USD Million)
  • Fig. 77 MEA Nebulizer market, by type, 2016 - 2027 (USD Million)
  • Fig. 78 MEA Nebulizer market, by end use, 2016 - 2027 (USD Million)
  • Fig. 79 South Africa Nebulizer market, 2016 - 2027 (USD Million)
目次
Product Code: GVR-2-68038-069-9

The global nebulizer market size is expected to reach USD 1.5 billion by 2027, expanding at a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research,. Rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population worldwide are the major factors leading to market growth.

According to the Population Reference Bureau report, "Aging in the United States", the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. Therefore, growing geriatric population is expected to expand the patient pool for manufacturers and propel the growth of the market.

On the other hand, drug loss during nebulization is the major factor restraining the market. However, this can also act as an opportunity for the mesh nebulizer manufacturers as the devices are manufactured to deliver accurate drug dosage while reduce drug loss. Furthermore, increasing commercial acceptance of mesh nebulizers due to accurate delivery of drug to the lung and lower residual volumes also aids in market growth.

Technological advancements such as drug-device combination is further expected to create new opportunity in the market. The key manufacturers are expected to dominate the market of drug device combinations till the generic mesh nebulizer manufacturers invest in the support infrastructure required for the development of new pharmaceuticals. For instance, in 2016, Sunovion filed the first application for the approval of SUN-101. A mesh nebulizer in combination with a drug for COPD (SUN-101) will be a significant step for boosting the adoption of nebulizers. Other companies such as Vectura also have products in late stage development, e.g., VR475, indicated for severe asthma, in Phase III trials.

Further key findings from the study suggest:

The jet segment held over 60.0% market share in 2019 owing to the greater penetration and low cost of the devices

The mesh segment is expected to be the fastest growing segment with a CAGR of 7.7% over the forecast period, due to various benefits including portability, convenience, homecare application, and accurate dosage delivery

According to the Population Reference Bureau report, "Aging in the United States", the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060

The demand is expected to increase in homecare application. Easy availability of compact nebulizers that are ideal for home use and technological innovations in the device to reduce the sound created by it and to improve its functionality are increasing its adoption in home healthcare

North America dominated the nebulizer market in 2019. This high share can be attributed to increase in incidence of respiratory diseases, supportive government policies, favorable reimbursement schemes, rise in awareness, and increasing use of home care products

As per the analysis of the U.S. and EU clinical trial databases, mesh nebulizers are more preferred for clinical trials sponsored by pharmaceutical companies over jet nebulizers

Key players include Omron Corporation; Koninklijke Philips N.V.; PARI Pharma; Allied Healthcare Products, Inc.; Becton Dickinson and Company; Agilent Technologies; Medline Industries; Briggs Healthcare; Drive Medical; and GF Health Products, Inc.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Type
    • 1.1.2 End use
    • 1.1.3 Regional scope
    • 1.1.4 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.2 Volume price analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume price analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Outlook

Chapter 3 Nebulizer Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 User Perspective Analysis
    • 3.3.1 Market influencer analysis
  • 3.4 List of Key End Users
  • 3.5 Regulatory Framework
    • 3.5.1 Regulatory Landscape
  • 3.6 Technology Overview
    • 3.6.1 Nebulizer timeline analysis
  • 3.7 Market Dynamics
    • 3.7.1 Market driver analysis
      • 3.7.1.1 Rising incidence of chronic respiratory diseases
      • 3.7.1.2 Increasing demand for home healthcare devices
      • 3.7.1.3 Expanding geriatric population base and increasing use of portable nebulizers
    • 3.7.2 Market restrain analysis
      • 3.7.2.1 Drug loss during drug delivery
      • 3.7.2.2 Availability of nebulizer substitute
  • 3.8 Nebulizer Analysis Tools: Porter's
    • 3.8.1 Supplier Power
    • 3.8.2 Buyer Power
    • 3.8.3 Threat of Substitutes
    • 3.8.4 Threat of New Entrants
    • 3.8.5 Competitive Rivalry
  • 3.9 Nebulizer Market - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
    • 3.9.1 Political Landscape
    • 3.9.2 Economic Landscape
    • 3.9.3 Social Landscape
    • 3.9.4 Technology Landscape
    • 3.9.5 Legal Landscape
    • 3.9.6 Respiratory Disease Prevalence
    • 3.9.7 Major Deals and Strategic Alliances

Chapter 4 Nebulizer Market: Competitive Analysis

  • 4.1 Market Participation Categorization
  • 4.2 Competitive Analysis
    • 4.2.1 Company market position analysis
    • 4.2.2 Market leader
    • 4.2.3 Innovators
    • 4.2.4 Vendor Landscape
      • 4.2.4.1 List of nebulizer service providers

Chapter 5 Nebulizer Market: Segment Analysis, By Type, 2016 - 2027 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 Type Market Share Analysis, 2019 & 2027
  • 5.3 Segment Dashboard
  • 5.4 Global Nebulizer Market, by Type, 2016 to 2027
  • 5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
    • 5.5.1 Jet nebulizer
      • 5.5.1.1 Jet nebulizer market, 2016 - 2027 (USD Million)
    • 5.5.2 Mesh nebulizer
      • 5.5.2.1 Mesh nebulizer market, 2016 - 2027 (USD Million)
    • 5.5.3 Ultrasonic nebulizer
      • 5.5.3.1 Ultrasonic nebulizer market, 2016 - 2027 (USD Million)

Chapter 6 Nebulizer Market: Segment Analysis, By End Use, 2016 - 2027 (USD Million)

  • 6.1 Definition and Scope
  • 6.2 End Use Market Share Analysis, 2019 & 2027
  • 6.3 Segment Dashboard
  • 6.4 Global Nebulizer Market, by End Use, 2016 to 2027
  • 6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
    • 6.5.1 Hospitals and Clinics
      • 6.5.1.1 Hospitals and Clinics market, 2016 - 2027 (USD Million)
    • 6.5.2 Emergency Centers
      • 6.5.2.1 Emergency Centers market, 2016 - 2027 (USD Million)
    • 6.5.3 Home Healthcare
      • 6.5.3.1 Home Healthcare market, 2016 - 2027 (USD Million)

Chapter 7 Nebulizer Market: Regional Market Analysis, By Type and End Use, 2016 - 2027 (USD Million)

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2019 & 2027
  • 7.3 Regional Market Dashboard
  • 7.4 Global Nebulizer Market, by Regions, 2016 to 2027
  • 7.5 Regional Market Snapshot
  • 7.6 Market Size, & Forecasts, Volume and Trend Analysis, 2016 to 2027
  • 7.7 North America
    • 7.7.1 North America Market estimates and forecast, by country, 2016-2027 (USD Million)
    • 7.7.2 North America Nebulizer market, by type, 2016 - 2027 (USD Million)
    • 7.7.3 North America Nebulizer market, by end use, 2016 - 2027 (USD Million)
    • 7.7.4 U.S.
      • 7.7.4.1 U.S. Nebulizer market, 2016 - 2027 (USD Million)
    • 7.7.5 Canada
      • 7.7.5.1 Canada Nebulizer market, 2016 - 2027 (USD Million)
  • 7.8 Europe
    • 7.8.1 Europe Nebulizer market, by country, 2016 - 2027 (USD Million)
    • 7.8.2 Europe Nebulizer market, by type, 2016 - 2027 (USD Million)
    • 7.8.3 Europe Nebulizer market, by end use, 2016 - 2027 (USD Million)
    • 7.8.4 U.K.
      • 7.8.4.1 U.K. Nebulizer market, 2016 - 2027 (USD Million)
    • 7.8.5 Germany
      • 7.8.5.1 Germany Nebulizer market, 2016 - 2027 (USD Million)
    • 7.8.6 France
      • 7.8.6.1 France Nebulizer market, 2016 - 2027 (USD Million)
    • 7.8.7 Italy
      • 7.8.7.1 Italy Nebulizer market, 2016 - 2027 (USD Million)
    • 7.8.8 Spain
      • 7.8.8.1 Spain Nebulizer market, 2016 - 2027 (USD Million)
    • 7.8.9 Russia
      • 7.8.9.1 Russia Nebulizer market, 2016 - 2027 (USD Million)
  • 7.9 Asia Pacific
    • 7.9.1 Asia Pacific Nebulizer market, by country, 2016 - 2027 (USD Million)
    • 7.9.2 Asia Pacific Nebulizer market, by type, 2016 - 2027 (USD Million)
    • 7.9.3 Asia Pacific Nebulizer market, by end use, 2016 - 2027 (USD Million)
    • 7.9.4 Japan
      • 7.9.4.1 Japan Nebulizer market, 2016 - 2027 (USD Million)
    • 7.9.5 China
      • 7.9.5.1 China Nebulizer market, 2016 - 2027 (USD Million)
    • 7.9.6 India
      • 7.9.6.1 India Nebulizer market, 2016 - 2027 (USD Million)
    • 7.9.7 Malaysia
      • 7.9.7.1 Malaysia Nebulizer market, 2016 - 2027 (USD Million)
    • 7.9.8 Singapore
      • 7.9.8.1 Singapore Nebulizer market, 2016 - 2027 (USD Million)
    • 7.9.9 Philippines
      • 7.9.9.1 Philippines Nebulizer market, 2016 - 2027 (USD Million)
    • 7.9.10 Indonesia
      • 7.9.10.1 Indonesia Nebulizer market, 2016 - 2027 (USD Million)
  • 7.10 Latin America
    • 7.10.1 Latin America Nebulizer market, by country, 2016 - 2027 (USD Million)
    • 7.10.2 Latin America Nebulizer market, by type, 2016 - 2027 (USD Million)
    • 7.10.3 Latin America Nebulizer market, by end use, 2016 - 2027 (USD Million)
    • 7.10.4 Brazil
      • 7.10.4.1 Brazil Nebulizer market, 2016 - 2027 (USD Million)
    • 7.10.5 Mexico
      • 7.10.5.1 Mexico Nebulizer market, 2016 - 2027 (USD Million)
  • 7.11 MEA
    • 7.11.1 MEA Nebulizer market, by country 2016 - 2027 (USD Million)
    • 7.11.2 MEA Nebulizer market, by type, 2016 - 2027 (USD Million)
    • 7.11.3 MEA Nebulizer market, by end use, 2016 - 2027 (USD Million)
    • 7.11.4 South Africa
      • 7.11.4.1 South Africa Nebulizer market, 2016 - 2027 (USD Million)

Chapter 8 Nebulizer Market - Competitive Analysis

  • 8.1 Rossmax International Ltd.
    • 8.1.1 Company Overview
    • 8.1.2 Product Benchmarking
    • 8.1.3 Strategic Initiatives
  • 8.2 OMRON Corporation
    • 8.2.1 Company overview
    • 8.2.2 Financial performance
    • 8.2.3 Product benchmarking
    • 8.2.4 Strategic initiatives
  • 8.3 Koninklijke Philips N.V.
    • 8.3.1 Company overview
    • 8.3.2 Financial performance
    • 8.3.3 Product benchmarking
    • 8.3.4 Strategic initiatives
  • 8.4 PARI Pharma
    • 8.4.1 Company overview
    • 8.4.2 Product benchmarking
    • 8.4.3 Strategic initiatives
  • 8.5 BD
    • 8.5.1 Company overview
    • 8.5.2 Financial performance
    • 8.5.3 Product benchmarking
    • 8.5.4 Strategic initiatives
  • 8.6 Medline Industries, Inc.
    • 8.6.1 Company overview
    • 8.6.2 Product benchmarking
    • 8.6.3 Strategic initiatives
  • 8.7 Briggs Healthcare
    • 8.7.1 Company overview
    • 8.7.2 Product benchmarking
    • 8.7.3 Strategic initiatives
  • 8.8 GF Health Products, Inc.
    • 8.8.1 Company overview
    • 8.8.2 Product benchmarking
    • 8.8.3 Strategic initiatives
  • 8.9 Vectura Group plc
    • 8.9.1 Company Overview
    • 8.9.2 Financial Performance
    • 8.9.3 Product Benchmarking
    • 8.9.4 Strategic Initiatives
  • 8.10 Beurer GmBH
    • 8.10.1 Company Overview
    • 8.10.2 Product Benchmarking
    • 8.10.3 Strategic Initiatives
    • 8.10.4 KOL commentary
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.